These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34789243)

  • 41. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
    Lagi F; Trevisan S; Piccica M; Graziani L; Basile G; Mencarini J; Borchi B; Menicacci L; Vaudo M; Scotti V; Fabbri A; Bandini G; Tozzetti C; Berni A; Aiezza N; Pestelli G; Turchi V; Pignone AM; Poggesi L; Nozzoli C; Morettini A; Rossolini GM; Bartoloni A
    Int J Infect Dis; 2021 Jul; 108():231-236. PubMed ID: 33901656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reviewing and Reflecting on Nursing During the COVID-19 Pandemic].
    Chen SL
    Hu Li Za Zhi; 2020 Dec; 67(6):4-5. PubMed ID: 33274419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is saliva a reliable biofluid for the detection of COVID-19?
    Torul D; Omezli MM
    Dent Med Probl; 2021; 58(2):229-235. PubMed ID: 34043887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection.
    Li K; Tong C; Ha X; Zeng C; Chen X; Xu F; Yang J; Du H; Chen Y; Cai J; Yang Z; Jiang Z; Chai D; Zhang X; Li X; Li J; Yao L
    BMC Infect Dis; 2021 Aug; 21(1):860. PubMed ID: 34425781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China.
    Chen Z; Wang B; Mao S; Ye Q
    Int J Biol Sci; 2021; 17(4):1119-1124. PubMed ID: 33867834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mining the Characteristics of COVID-19 Patients in China: Analysis of Social Media Posts.
    Huang C; Xu X; Cai Y; Ge Q; Zeng G; Li X; Zhang W; Ji C; Yang L
    J Med Internet Res; 2020 May; 22(5):e19087. PubMed ID: 32401210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 diagnosis from chest X-ray images using transfer learning: Enhanced performance by debiasing dataloader.
    Polat Ç; Karaman O; Karaman C; Korkmaz G; Balcı MC; Kelek SE
    J Xray Sci Technol; 2021; 29(1):19-36. PubMed ID: 33459685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada.
    Ng V; Fazil A; Waddell LA; Bancej C; Turgeon P; Otten A; Atchessi N; Ogden NH
    CMAJ; 2020 Sep; 192(37):E1053-E1064. PubMed ID: 32778573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory diagnosis of novel corona virus (2019-nCoV)-present and the future.
    Sidiq Z; Hanif M; Dwivedi KK; Chopra KK
    Indian J Tuberc; 2020 Dec; 67(4S):S128-S131. PubMed ID: 33308658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
    Lagier JC; Colson P; Tissot Dupont H; Salomon J; Doudier B; Aubry C; Gouriet F; Baron S; Dudouet P; Flores R; Ailhaud L; Gautret P; Parola P; La Scola B; Raoult D; Brouqui P
    Travel Med Infect Dis; 2020; 34():101624. PubMed ID: 32179125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population-Based COVID-19 Screening in Mexico: Assessment of Symptoms and Their Weighting in Predicting SARS-CoV-2 Infection.
    Martinez-Fierro ML; Diaz-Lozano M; Alvarez-Zuñiga C; Ramirez-Hernandez LA; Araujo-Espino R; Trejo-Ortiz PM; Mollinedo-Montaño FE; Ortiz-Castro Y; Vazquez-Reyes S; Velasco-Elizondo P; Garcia-Esquivel L; Araujo-Conejo A; Garza-Veloz I
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917858
    [No Abstract]   [Full Text] [Related]  

  • 54. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spring in London with Covid-19: a personal view.
    Brahams D
    Med Leg J; 2020 Jul; 88(2):57-64. PubMed ID: 32515258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus.
    Koenig KL; Beÿ CK; McDonald EC
    West J Emerg Med; 2020 Jan; 21(2):184-190. PubMed ID: 32191174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical laboratory and dispersion pattern of COVID-19 in a family cluster in the social-distancing period.
    Brito CAA; Brito MCM; Martins THF; Brito CCM; Albuquerque MFM; Brito RCCM
    J Infect Dev Ctries; 2020 Sep; 14(9):987-993. PubMed ID: 33031086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19.
    Cai X; Jiang H; Zhang S; Xia S; Du W; Ma Y; Yu T; Li W
    Front Med; 2020 Dec; 14(6):776-785. PubMed ID: 33106939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interpreting SARS-CoV-2 Diagnostic Tests: Common Questions and Answers.
    Nettleton WD
    Am Fam Physician; 2021 Apr; 103(8):465-472. PubMed ID: 33856162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
    Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
    J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.